Abstract
Tobacco smoke (TS) exposure of children causes significant and completely preventable morbidity and mortality. The primary source of the TS to which children are exposed is smoking by parents or family members in the home. Clinicians who care for children can and should counsel families to make the childs environment completely smoke free and ultimately, to quit using tobacco altogether. In as little as three minutes, counseling to make environments smoke free and tobacco users to quit can be delivered. Basic techniques of behavior change counseling and cessation resources for families are discussed, including stages of change, the “Five As,” brief motivational messaging, and pharmacotherapies. The evidence supporting counseling of parents and patients to promote smoke free homes and tobacco use cessation is presented. Policies that promote smoke free homes are discussed briefly.
Keywords: Child, nicotine, nicotine dependence, parents, passive smoking, smoke, smoking, smoking cessation, tobacco, tobacco smoke pollution, tobacco use disorder
Current Pediatric Reviews
Title: Prevention and Management of Tobacco Smoke Exposure of Children in the Clinical Setting
Volume: 7 Issue: 2
Author(s): Dana Best
Affiliation:
Keywords: Child, nicotine, nicotine dependence, parents, passive smoking, smoke, smoking, smoking cessation, tobacco, tobacco smoke pollution, tobacco use disorder
Abstract: Tobacco smoke (TS) exposure of children causes significant and completely preventable morbidity and mortality. The primary source of the TS to which children are exposed is smoking by parents or family members in the home. Clinicians who care for children can and should counsel families to make the childs environment completely smoke free and ultimately, to quit using tobacco altogether. In as little as three minutes, counseling to make environments smoke free and tobacco users to quit can be delivered. Basic techniques of behavior change counseling and cessation resources for families are discussed, including stages of change, the “Five As,” brief motivational messaging, and pharmacotherapies. The evidence supporting counseling of parents and patients to promote smoke free homes and tobacco use cessation is presented. Policies that promote smoke free homes are discussed briefly.
Export Options
About this article
Cite this article as:
Best Dana, Prevention and Management of Tobacco Smoke Exposure of Children in the Clinical Setting, Current Pediatric Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339611795735558
DOI https://dx.doi.org/10.2174/157339611795735558 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Ion Channels in Leukemias: A New Challenge for Treatment
Current Medicinal Chemistry Glucolipotoxicity-induced Oxidative Stress is Related to Mitochondrial Dysfunction and Apoptosis of Pancreatic β-cell
Current Diabetes Reviews Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets Investigation of Antioxidant Activity and Analysis of Phenolic Compounds of some Asteraceae Plants by HPLC: A Comparison Between Methanol and Ethanol Extracts
Current Nutraceuticals Modern Perspectives on the Structure, Function and Evolution of the Relaxin-Like Peptides and their Receptors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Vaccine Ingredients: Components that Influence Vaccine Efficacy
Mini-Reviews in Medicinal Chemistry The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Effective Anticancer Drug and Food Choices Based on Polyamine Levels in Cancer Tissues
Current Drug Therapy Assessment of Thyroid Disorders and Autoimmunity in Patients with Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacokinetic Concepts Revisited - Basic and Applied
Current Pharmaceutical Biotechnology LAT1 Targeted Delivery of Methionine Based Imaging Probe Derived from M(III) Metal Ions for Early Diagnosis of Proliferating Tumours using Molecular Imaging Modalities
Current Cancer Drug Targets Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Genes for Anti-HIV/AIDS Gene Therapy
Current Pharmaceutical Biotechnology Recent Patents on Molecular Cytogenetics
Recent Patents on DNA & Gene Sequences The Protective Action of the Aqueous Extract of Auricularia polytricha in Paracetamol Induced Hepatotoxicity in Rats
Recent Patents on Drug Delivery & Formulation Roles of NHERF1/EBP50 in Cancer
Current Molecular Medicine Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies
Current Diabetes Reviews Nephrotoxicity Associated with Antiretroviral Therapy in HIV-Infected Patients
Current Drug Safety Probenecid: An Emerging Tool for Neuroprotection
CNS & Neurological Disorders - Drug Targets The “Aged Garlic Extract” (AGE) and One of its Active Ingredients S-Allyl-LCysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD)
Current Medicinal Chemistry